A comprehensive view of PharmaJet Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

PharmaJet announces successful trial of GEMCOVAC-OM, a novel self-amplifying mRNA vaccine for COVID19, delivered intradermally through its needle-free Tropis ID System; trial showed a significant boost in immune response against the Omicron variant
Published: April 29, 2024 by PharmaJet Inc.
PharmaJet announces start of the first human clinical trial for a Venezuelan Equine Encephalitis DNA vaccine delivered with PharmaJet precision delivery systems; VEE listed as a potential biothreat agent
Published: November 16, 2023 by PharmaJet Inc.
PharmaJet receives strategic investment from Japanese chemical firm Daicel Corp.; the investment will aid PharmaJet in expanding their business and partnerships
Published: October 31, 2023 by Business Wire
PharmaJet launches study in Nigeria to evaluate impact of needle-free polio vaccine delivery system on immunization programs; study aims to address high costs, supply issues and vaccine hesitancy while improving coverage rates
Published: October 24, 2023 by Business Wire
PharmaJet announces its Tropis intradermal delivery system is the exclusive delivery device for nucleic acid COVID-19 vaccines from Zydus Lifesciences and Gennova Biopharmaceuticals
Published: June 28, 2023 by PharmaJet Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count